Evidence map›Paper›PMID 28445475›Full record

ArticlePLoS genetics2017

GRHL3 binding and enhancers rearrange as epidermal keratinocytes transition between functional states.

Rachel Herndon Klein, Ziguang Lin, Amelia Soto Hopkin, William Gordon, Lam C Tsoi, Yun Liang, Johann E Gudjonsson, Bogi Andersen

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Chromatin Landscape Governing Murine Epidermal Differentiation.The Journal of investigative dermatology · 2023
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Rachel Herndon KleinDepartment of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, California, United States of America.
Ziguang LinDepartment of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, California, United States of America.
Amelia Soto HopkinDepartment of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, California, United States of America.
William GordonDepartment of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, California, United States of America.
Lam C TsoiDepartment of Dermatology, University of Michigan, Ann Arbor, Michigan, United States of America.ORCID 0000-0003-1627-5722
Yun LiangDepartment of Dermatology, University of Michigan, Ann Arbor, Michigan, United States of America.ORCID 0000-0001-8430-3321
Johann E GudjonssonDepartment of Dermatology, University of Michigan, Ann Arbor, Michigan, United States of America.
Bogi AndersenDepartment of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, California, United States of America.ORCID 0000-0001-7181-2768
University of California, Irvine · USUniversity of Michigan · US

Funding

University of California Health Participation in the National COVID Cohort Collaborative (N3C)UL1TR001414 · NCATS · UNIVERSITY OF CALIFORNIA-IRVINE · PI COOPER, DAN M, VILAIN, ERIC J. · 2015 to 2023
$35.1M
Transcriptional Co-Regulators in EpidermisR01AR044882 · NIAMS · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI Bogi Andersen · 1998 to 2026
$9.0M
TRAINING PROGRAM IN CELL AND MOLECULAR DERMATOLOGYT32AR007197 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI JAMES TILFORD ELDER, Sunny Y Wong · 1986 to 2026
$4.2M
Role of IL-13 and the IL-13 Associated rs20541 Risk Variant in the Pathogenesis of PsoriasisR01AR069071 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GUDJONSSON, JOHANN ELI · 2015 to 2019
$2.1M
Training Program in Systems Biology of DevelopmentT32HD060555 · NICHD · UNIVERSITY OF CALIFORNIA-IRVINE · PI LANDER, ARTHUR D · 2009 to 2013
$1.3M
NCATS NIH HHS UL1 TR001414NIAMS NIH HHS R01 AR044882NIAMS NIH HHS R01 AR069071NIAMS NIH HHS T32 AR007197NICHD NIH HHS T32 HD060555
6 · The paper itself

Abstract

Transcription factor binding, chromatin modifications and large scale chromatin re-organization underlie progressive, irreversible cell lineage commitments and differentiation. We know little, however, about chromatin changes as cells enter transient, reversible states such as migration. Here we demonstrate that when human progenitor keratinocytes either differentiate or migrate they form complements of typical enhancers and super-enhancers that are unique for each state. Unique super-enhancers for each cellular state link to gene expression that confers functions associated with the respective cell state. These super-enhancers are also enriched for skin disease sequence variants. GRHL3, a transcription factor that promotes both differentiation and migration, binds preferentially to super-enhancers in differentiating keratinocytes, while during migration, it binds preferentially to promoters along with REST, repressing the expression of migration inhibitors. Key epidermal differentiation transcription factor genes, including GRHL3, are located within super-enhancers, and many of these transcription factors in turn bind to and regulate super-enhancers. Furthermore, GRHL3 represses the formation of a number of progenitor and non-keratinocyte super-enhancers in differentiating keratinocytes. Hence, chromatin relocates GRHL3 binding and enhancers to regulate both the irreversible commitment of progenitor keratinocytes to differentiation and their reversible transition to migration.

Indexed as

Enhancer Elements, GeneticCell DifferentiationCell LineageCell MovementChromatinDNA-Binding ProteinsEpidermisGene Expression Regulation, DevelopmentalHumansKeratinocytesPromoter Regions, GeneticProtein BindingTranscription FactorsChromatinDNA-Binding ProteinsGRHL3 protein, humanTranscription Factors

Identifiers

PMID28445475
PMCPMC5425218
OpenAlexW2609050486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.